Table 1.
Baseline characteristics of patients according to clinical outcomes
| Clinical outcomes | ||||||
|---|---|---|---|---|---|---|
| Good | Non‐good | P‐value | Survival | Death | P‐valuea | |
| Clinical information | ||||||
| Age | 65.93±12.17 | 69.32±12.65 | <.001 | 68.05±12.56 | 70.95±12.75 | .035 |
| Gender (male/female) | 147/99 | 362/263 | .621 | 447/330 | 62/32 | .117 |
| Smoking (yes/no) | 64/182 | 156/469 | .747 | 212/685 | 27/67 | .273 |
| Baseline NIHSS | 8 (2‐11) | 8 (3‐13) | .074 | 8 (2‐11) | 8 (4‐13) | .011 |
| Medical history | ||||||
| Hypertension | 137 (55.69) | 388 (62.08) | .083 | 463 (59.59) | 62 (65.96) | .233 |
| Diabetes mellitus | 62 (25.20) | 124 (19.84) | .082 | 173 (22.27) | 27 (28.72) | .160 |
| Atrial fibrillation | 54 (21.95) | 138 (22.08) | .967 | 176 (22.65) | 16 (17.02) | .213 |
| TIA | 6 (2.44) | 18 (2.88) | .720 | 22 (2.83) | 2 (2.13) | .694 |
| Stroke etiology | ||||||
| Atherosclerotic | 204 (82.93) | 504 (80.64) | .568 | 630 (81.08) | 78 (82.98) | .870 |
| Cardioembolic | 31 (12.60) | 96 (15.36) | 115 (14.80) | 12 (12.77) | ||
| Cryptogenic | 11 (4.47) | 25 (4.00) | 32 (4.12) | 4 (4.26) | ||
| Laboratory characteristics | ||||||
| WBC (109/L) | 7.37 (5.79‐9.34) | 7.74 (6.12‐9.61) | .083 | 7.62 (6.01‐9.54) | 7.93 (6.28‐9.63) | .236 |
| Platelet (109/L) | 185 (144‐217) | 181 (149‐216) | .563 | 180 (147‐216) | 191 (153‐220) | .223 |
| Glucose (mmol/L) | 6.37 (5.32‐8.01) | 6.39 (5.28‐8.11) | .742 | 6.37 (5.28‐8.07) | 6.75 (5.36‐8.15) | .171 |
| Creatinine (mmol/L) | 75 (65‐88) | 75 (62‐87) | .234 | 75 (64‐89) | 71 (60‐81) | .011 |
| TC (mmol/L) | 4.21 (3.92‐4.78) | 4.37 (4.07‐5.01) | <.001 | 4.35 (4.04‐5.00) | 4.15 (3.80‐4.69) | <.001 |
| HDL‐C (mmol/L) | 1.26 (1.12‐1.51) | 1.22 (1.10‐1.45) | .044 | 1.23 (1.10‐1.45) | 1.27 (1.13‐1.52) | .186 |
| LDL‐C (mmol/L) | 2.83 (2.40‐3.34) | 2.90 (2.51‐3.47) | .076 | 2.90 (2.51‐3.45) | 2.76 (2.37‐3.39) | .064 |
| Non‐HDL‐C (mmol/L) | 2.90 (2.64‐3.43) | 3.13 (2.74‐3.81) | <.001 | 3.10 (2.73‐3.78) | 2.81 (2.58‐3.15) | <.001 |
| TC/HDL‐C | 3.41 (2.88‐3.88) | 3.59 (3.16‐4.32) | <.001 | 3.54 (3.15‐4.31) | 3.24 (2.79‐3.76) | <.001 |
NIHSS, NIH Stroke Scale; TIA, transient ischaemic attack; WBC, white blood cell; TC, total cholesterol; HDL‐C, high‐density lipoprotein cholesterol; LDL‐C, low‐density lipoprotein cholesterol; TC/HDL‐C, TC to HDL‐C ratio
Good outcome is defined as mRS of 0‐2 or equal to prestroke mRS.
Values are medians (interquartile range) or frequencies and percentages if necessary. Statistically significant results are in italic font.
Chi‐squared test or Mann–Whitney U test as appropriate.